Ibrutinib Plus Venetoclax Long-Term Outcomes in CLL

Clinical trial NCT07774390 · RECRUITING

Trial details

NCT number: NCT07774390
Sponsor: European Research Initiative on CLL
Status: RECRUITING
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)

Start date: 2025-12-18
Primary completion: 2028-03-01
Enrollment: 323

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.